InnovAge Holding Corp. Net Income (Loss) Attributable to Redeemable Noncontrolling Interest
InnovAge Holding Corp. (INNV) reported Net Income (Loss) Attributable to Redeemable Noncontrolling Interest of $4.82 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest · last filed 2026-09-09
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2026-06-30 was $2.08M, a 328.13% increase year-over-year.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2026-03-31 was $154.00K, a 68.51% decline year-over-year.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2025-12-31 was $1.66M.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2025-09-30 was $927.00K.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2026 was $4.82M, a 1146.51% increase from fiscal 2025.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2025 was $387.00K.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2024 was -$1.54M.
- InnovAge Holding Corp. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2023 was -$2.57M.
| Period end | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $2.24M derived: sum of 2 quarters · filed 2026-09-09 | $3.90M derived: sum of 3 quarters · filed 2026-09-09 | $4.82M 10-K · filed 2026-09-09 | ||||
| 2026-03-31 | $154.00K 10-Q · filed 2026-05-08 | $1.81M derived: sum of 2 quarters · filed 2026-05-08 | $2.74M 10-Q · filed 2026-05-08 | $3.23M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-12-31 | $1.66M 10-Q · filed 2026-02-03 | $2.58M 10-Q · filed 2026-02-03 | $3.07M derived: sum of 3 quarters · filed 2026-09-09 | $3.56M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-09-30 | $927.00K 10-Q · filed 2025-11-04 | $1.41M derived: sum of 2 quarters · filed 2026-09-09 | $1.90M derived: sum of 3 quarters · filed 2026-09-09 | $1.86M derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-06-30 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $976.00K derived: sum of 2 quarters · filed 2026-09-09 | $930.00K derived: sum of 3 quarters · filed 2026-09-09 | $387.00K 10-K · filed 2026-09-09 | ||||
| 2025-03-31 | $489.00K 10-Q · filed 2026-05-08 | $443.00K derived: sum of 2 quarters · filed 2026-05-08 | -$100.00K 10-Q · filed 2026-05-08 | -$517.00K derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$46.00K 10-Q · filed 2026-02-03 | -$589.00K 10-Q · filed 2026-02-03 | -$1.01M derived: sum of 3 quarters · filed 2026-02-03 | -$1.25M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-09-30 | -$543.00K 10-Q · filed 2025-11-04 | -$960.00K derived: sum of 2 quarters · filed 2025-11-04 | -$1.20M derived: sum of 3 quarters · filed 2025-11-04 | -$1.51M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | -$417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$660.00K derived: sum of 2 quarters · filed 2025-09-09 | -$967.00K derived: sum of 3 quarters · filed 2025-09-09 | -$1.54M 10-K · filed 2025-09-09 | ||||
| 2024-03-31 | -$243.00K 10-Q · filed 2025-05-06 | -$550.00K derived: sum of 2 quarters · filed 2025-05-06 | -$1.12M 10-Q · filed 2025-05-06 | -$1.87M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | -$307.00K 10-Q · filed 2025-02-04 | -$877.00K 10-Q · filed 2025-02-04 | -$1.63M derived: sum of 3 quarters · filed 2025-02-04 | -$2.22M derived: sum of 4 quarters · filed 2025-02-04 | ||||
| 2023-09-30 | -$570.00K 10-Q · filed 2024-11-05 | -$1.32M derived: sum of 2 quarters · filed 2024-11-05 | -$1.92M derived: sum of 3 quarters · filed 2024-11-05 | -$2.60M derived: sum of 4 quarters · filed 2024-11-05 | ||||
| 2023-06-30 | -$753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$1.35M derived: sum of 2 quarters · filed 2024-09-10 | -$2.03M derived: sum of 3 quarters · filed 2024-09-10 | -$2.57M 10-K · filed 2024-09-10 | ||||
| 2023-03-31 | -$593.00K 10-Q · filed 2024-05-07 | -$1.27M derived: sum of 2 quarters · filed 2024-05-07 | -$1.82M 10-Q · filed 2024-05-07 | -$2.54M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$680.00K 10-Q · filed 2024-02-06 | -$10.55M 10-Q · filed 2023-02-07 | -$1.22M 10-Q · filed 2024-02-06 | -$24.25M 10-Q · filed 2023-02-07 | -$1.94M derived: sum of 3 quarters · filed 2024-02-06 | -$2.23M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2022-09-30 | -$544.00K 10-Q · filed 2023-11-07 | -$13.70M 10-Q · filed 2022-11-08 | -$1.26M derived: sum of 2 quarters · filed 2023-11-07 | -$1.55M derived: sum of 3 quarters · filed 2023-11-07 | -$446.00K derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | -$718.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$1.01M derived: sum of 2 quarters · filed 2023-09-12 | $98.00K derived: sum of 3 quarters · filed 2023-09-12 | -$1.12M 10-K · filed 2023-09-12 | -$7.96M 10-K · filed 2022-09-13 | |||
| 2022-03-31 | -$290.00K 10-Q · filed 2023-05-09 | -$3.16M 10-Q · filed 2022-05-10 | $816.00K derived: sum of 2 quarters · filed 2023-05-09 | -$403.00K 10-Q · filed 2023-05-09 | $5.57M 10-Q · filed 2022-05-10 | $14.76M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $1.11M 10-Q · filed 2023-02-07 | $8.73M 10-Q · filed 2023-02-07 | $15.04M derived: sum of 3 quarters · filed 2023-02-07 | $4.18M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-09-30 | $7.62M 10-Q · filed 2022-11-08 | $13.94M derived: sum of 2 quarters · filed 2022-11-08 | $3.08M derived: sum of 3 quarters · filed 2022-11-08 | |||||
| 2021-06-30 | $6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$4.55M derived: sum of 2 quarters · filed 2022-09-13 | -$44.74M 10-K · filed 2022-09-13 | |||||
| 2021-03-31 | -$10.86M 10-Q · filed 2022-05-10 | -$51.05M 10-Q · filed 2022-05-10 | ||||||
| 2020-09-30 | -$49.80M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |